The novel coronavirus has dramatically affected our world, with millions infected and many lives lost. The pandemic has caused economic instability, job losses, and widespread social isolation. Everyone is eager to know when this crisis will end, but predicting the future is challenging. Experts suggest that the worst may pass in a few months, but the virus could linger, potentially returning in waves or becoming a seasonal issue like the flu. While we hope for a natural resolution, the virus might not disappear on its own.
The current lockdown measures are not sustainable long-term. If the virus resurfaces, shutting down the world again would be overwhelming. Therefore, finding a way to prevent new infections is crucial, and the race for a vaccine is on. At least 35 vaccines are in development worldwide, with researchers working at unprecedented speeds. Among the most promising are RNA vaccines, which could transform how we combat infectious diseases.
Vaccines have been a cornerstone of modern medicine, preventing millions of deaths annually. They have eradicated diseases like smallpox and significantly reduced child mortality rates. Traditional vaccines work by introducing a weakened or inactivated form of a virus to the body, prompting the immune system to recognize and fight the virus without causing illness. This process involves T-cells and B-cells, which attack infected cells and produce antibodies, respectively.
While effective, traditional vaccine production can be slow and complex, especially during sudden outbreaks. For instance, the flu vaccine is produced using chicken eggs, which complicates and lengthens the process. This involves growing the virus in eggs, killing it, and purifying the antigens for inactivated vaccines, or modifying the virus for live attenuated vaccines.
Some coronavirus vaccine projects are using traditional methods, but others are exploring new technologies. Moderna, a leading company in this field, is developing an mRNA vaccine called mRNA-1273. This vaccine was created quickly after the coronavirus genome was sequenced in January. Scientists identified the spike protein on the virus’s surface as a target for the vaccine, as it plays a key role in the virus’s ability to infect human cells.
The mRNA vaccine works by encoding the spike protein’s genetic sequence into an mRNA molecule. This mRNA is then injected into the body, where it instructs cells to produce the spike protein, triggering an immune response. This method eliminates the need to grow the virus, significantly speeding up vaccine production. Unlike traditional vaccines, RNA vaccines can be developed in about a week in the lab.
RNA vaccines have shown promise in protecting against various infectious diseases, but they require thorough testing in humans. Vaccine development involves three phases of clinical trials: testing safety in a small group, assessing safety and efficacy in hundreds of people, and evaluating the vaccine in thousands. This process usually takes years, but efforts are underway to expedite it for the coronavirus vaccine.
Moderna has made significant strides, moving from genome sequencing to human testing in just 42 days. The first phase of testing for the mRNA vaccine has begun, and some experts believe it could be ready for approval in 18 months. This rapid progress is partly due to Moderna’s previous work on a MERS vaccine, which laid the groundwork for their current efforts.
As we navigate this pandemic, it’s important to stay safe, informed, and hopeful. For those with extra time, it’s an opportunity to learn new skills and expand knowledge. If you’re interested in science and math, consider exploring resources like Brilliant, which offers interactive challenges and courses, including one on computational biology. These resources can help you build problem-solving skills and make learning engaging and hands-on.
Research the different stages of vaccine development and approval. Prepare a presentation that explains these stages, highlighting the differences between traditional and RNA vaccines. Focus on the challenges and innovations in the current race for a COVID-19 vaccine.
Participate in a debate where you will argue either for traditional vaccines or RNA vaccines. Consider aspects such as speed of development, safety, cost, and long-term efficacy. This will help you understand the pros and cons of each approach.
Conduct a case study analysis of Moderna’s mRNA-1273 vaccine. Examine the timeline from genome sequencing to human testing, and discuss the factors that contributed to the rapid development. Reflect on how this case study could influence future vaccine development.
Join an interactive workshop that simulates the immune response triggered by vaccines. Use models to visualize how T-cells and B-cells work together to fight infections. This hands-on activity will deepen your understanding of the immune system’s role in vaccination.
Enroll in an online course focused on computational biology to explore how computational tools are used in vaccine development. This course will provide insights into the role of bioinformatics in identifying vaccine targets and predicting vaccine efficacy.
This episode of Real Science is brought to you by Brilliant, master concepts in math and science. Get 20% off by being one of the first 200 people to sign up at brilliant.org/realscience.
At this point, no one is unaware of the impact the novel coronavirus is having on society. Millions are infected, tens of thousands have died, financial markets are in turmoil, people are out of work, and social isolation is widespread. Everyone is wondering when this will end, which is the hardest question to answer. We are in uncharted waters. Experts estimate that the worst of the impact should be over in a few months, but even after this initial surge, there is a chance that the virus will persist in the population, potentially returning repeatedly. There is also a possibility that the virus could act seasonally, recurring every winter. Scientists and everyone else hope that this isn’t the case, but there is a chance it won’t go away on its own.
Even after only a few weeks, it is clear that this lockdown is unsustainable. If the virus does come back next year, the prospect of shutting the world down again is daunting. There is an urgent need to find a way to prevent new infections, and because of this, the race for a vaccine is on. Currently, there are at least 35 different vaccines in preliminary stages around the world. Researchers are moving at breakneck speeds, and progress is being made rapidly. The most promising vaccines right now are quite different from the traditional vaccines we are familiar with. This type of vaccine is called an RNA vaccine, and if successful, it could revolutionize the way we prevent infectious diseases.
Vaccines are one of medicine’s greatest inventions, preventing an estimated two to three million deaths every year. They have eradicated smallpox, reduced global child mortality rates, and prevented countless birth defects and lifelong disabilities, such as paralysis from polio. Historically, vaccines work by introducing a weakened or dead form of the virus to the body. These are called live attenuated vaccines and inactivated vaccines. The disease-causing traits of the virus are removed before being injected into the body. When these modified versions of the pathogen are introduced, the immune system recognizes the antigens that coat their surface, just as it would in an actual infection. The immune system reacts by producing certain types of white blood cells called T-cells and B-cells. T-cells attack infected cells, while B-cells produce antibodies that target the viral antigens.
This type of vaccine can be very effective at preventing certain diseases, but the manufacturing process can be cumbersome, especially during a sudden outbreak like the coronavirus. For example, the seasonal flu vaccine is made using a large number of eggs, which complicates and prolongs the production process. The process begins when the candidate flu virus is injected into fertilized chicken eggs, which are then incubated for several days to allow the viruses to replicate. For inactivated influenza vaccines, the viruses are killed, and the virus antigen is purified. For live attenuated vaccines, the process is even more involved, as the virus must be modified to no longer be infectious to humans while still producing an immune response.
Some coronavirus vaccine development projects are using traditional approaches, but others are employing newer technology to circumvent these challenges. One company, Moderna, is leading the charge in creating an mRNA vaccine that could be the first of its type approved for human use. The vaccine, called mRNA-1273, began development when the entire genome of the coronavirus was sequenced in January and uploaded to a public database. Scientists identified a key protein on the virus’s surface, called the spike protein, as a good vaccine candidate. The spike protein is crucial for the virus’s ability to enter human cells and is one of the major antigens that the human body can target with antibodies.
The nucleic acid sequence that codes for the spike protein was then encoded into a messenger RNA (mRNA) molecule. This mRNA can be replicated many times and administered directly to patients as a vaccine. Once inside the body, the mRNA instructs immune cells to produce copies of the spike protein, which then triggers an immune response. This novel approach is promising because it eliminates the need to propagate the virus to create a vaccine, significantly speeding up the process. In contrast to the months required for traditional vaccines, RNA vaccines can be made in the lab in about a week.
A recent study tested the effectiveness of RNA vaccines against various infectious diseases and found that they were successful in fully protecting against lethal exposures. While the scientific basis for the coronavirus RNA vaccine is sound, it still requires extensive testing in humans before it can be released to the public. Vaccine developers must be cautious, as there are risks involved, including the phenomenon known as disease enhancement, where vaccinated individuals may develop a more severe form of the disease if they become infected.
Clinical trials typically occur in three phases. Phase one involves a small group of healthy volunteers to test safety. Phase two includes several hundred people, usually in areas affected by the disease, to monitor safety and efficacy. Phase three tests the vaccine in several thousand people. This lengthy process means that vaccines usually take ten years or more to gain regulatory approval. However, for the new vaccines being developed, researchers and regulators are trying to fast-track the process without cutting corners.
Moderna has made remarkable progress, moving from obtaining the genetic sequence to developing a vaccine ready for human testing in just 42 days. Phase one of testing for the mRNA vaccine has just begun, with the first person being injected with the new vaccine recently. Some believe the vaccine could be ready for regulatory approval in 18 months, which is incredibly fast given the circumstances. One reason for this rapid development is the work Moderna has done over the past two years on a vaccine for the MERS virus, which set the stage for their current efforts.
As this situation unfolds, many of us are trying to stay safe, informed, and hopeful about the future while taking care of ourselves. For those with free time, it’s a great opportunity to read, work on projects, and learn new skills. If you’re a student looking to stay on top of your studies or someone wanting to understand the world better, consider checking out the math and science learning resources on Brilliant. With Brilliant, you can add structure to your daily routine by setting goals and working towards them. Their interactive challenges and quizzes make learning engaging and hands-on. If you’re interested in diving deeper into mRNA vaccines, Brilliant offers a course on computational biology that covers foundational concepts in molecular biology and cutting-edge problems.
If you want to build your problem-solving skills or use this time productively, sign up for Brilliant Premium to learn something new. The interactive content is a great way to learn, especially compared to traditional lecture-style learning, and you’ll be amazed at what you can master over time.
Vaccine – A biological preparation that provides active acquired immunity to a particular infectious disease. – The development of a new vaccine against the influenza virus is crucial to prevent future outbreaks.
Coronavirus – A group of related RNA viruses that cause diseases in mammals and birds, including the common cold and more severe forms like SARS and COVID-19. – Researchers are studying the coronavirus to understand its transmission and develop effective treatments.
RNA – Ribonucleic acid, a nucleic acid present in all living cells, primarily involved in the synthesis of proteins and carrying genetic information in some viruses. – The RNA sequence of the virus was analyzed to determine its potential impact on human health.
Immune – Relating to the complex network of cells and proteins that defends the body against infection. – The immune system’s response to pathogens is critical in preventing the spread of infections.
Proteins – Large, complex molecules that play many critical roles in the body, including catalyzing metabolic reactions and supporting immune function. – Proteins are essential for the structure, function, and regulation of the body’s tissues and organs.
Infections – The invasion and multiplication of microorganisms such as bacteria, viruses, and parasites that are not normally present within the body. – Antibiotics are used to treat bacterial infections, but they are ineffective against viruses.
Trials – Scientific studies conducted to evaluate the effectiveness and safety of a medical strategy, treatment, or device. – Clinical trials are essential for determining the safety and efficacy of new vaccines.
Antibodies – Proteins produced by the immune system that recognize and neutralize foreign substances such as bacteria and viruses. – The presence of specific antibodies in the blood can indicate a past infection or successful vaccination.
Genome – The complete set of genes or genetic material present in a cell or organism. – Sequencing the human genome has provided insights into genetic diseases and potential therapies.
Biology – The scientific study of life and living organisms, including their structure, function, growth, evolution, and distribution. – Advances in biology have led to significant breakthroughs in medicine and environmental science.
